File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Management of viral hepatitis A, C, D and E in pregnancy

TitleManagement of viral hepatitis A, C, D and E in pregnancy
Authors
KeywordsHepatitis A
Hepatitis C
Hepatitis D
Hepatitis E
Pregnancy
Issue Date2020
PublisherBailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpobgyn
Citation
Best Practice & Research: Clinical Obstetrics & Gynaecology, 2020, v. 68, p. 44-53 How to Cite?
AbstractViral hepatitis can cause significant maternal and neonatal morbidity and mortality. Hepatitis A and E mainly present as acute hepatitis during pregnancy, while hepatitis C and D are usually found as chronic infection in pregnant women. Hepatitis A remains self-limiting during pregnancy while hepatitis E has a higher prevalence and manifests with a rigorous course in pregnant women. Screening of hepatitis C during pregnancy and its subsequent management during pregnancy are still a debatable topic. New treatments of hepatitis C and E require further evaluation for use in pregnancy. This review summarizes the prevalence, clinical manifestations, maternal, foetal and neonatal effects, and the management of hepatitis A, C, D and E viral infection during pregnancy.
Persistent Identifierhttp://hdl.handle.net/10722/289387
ISSN
2021 Impact Factor: 4.268
2020 SCImago Journal Rankings: 1.622
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSeto, MTY-
dc.contributor.authorCheung, KW-
dc.contributor.authorHung, IFN-
dc.date.accessioned2020-10-22T08:11:56Z-
dc.date.available2020-10-22T08:11:56Z-
dc.date.issued2020-
dc.identifier.citationBest Practice & Research: Clinical Obstetrics & Gynaecology, 2020, v. 68, p. 44-53-
dc.identifier.issn1521-6934-
dc.identifier.urihttp://hdl.handle.net/10722/289387-
dc.description.abstractViral hepatitis can cause significant maternal and neonatal morbidity and mortality. Hepatitis A and E mainly present as acute hepatitis during pregnancy, while hepatitis C and D are usually found as chronic infection in pregnant women. Hepatitis A remains self-limiting during pregnancy while hepatitis E has a higher prevalence and manifests with a rigorous course in pregnant women. Screening of hepatitis C during pregnancy and its subsequent management during pregnancy are still a debatable topic. New treatments of hepatitis C and E require further evaluation for use in pregnancy. This review summarizes the prevalence, clinical manifestations, maternal, foetal and neonatal effects, and the management of hepatitis A, C, D and E viral infection during pregnancy.-
dc.languageeng-
dc.publisherBailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/bpobgyn-
dc.relation.ispartofBest Practice & Research: Clinical Obstetrics & Gynaecology-
dc.subjectHepatitis A-
dc.subjectHepatitis C-
dc.subjectHepatitis D-
dc.subjectHepatitis E-
dc.subjectPregnancy-
dc.titleManagement of viral hepatitis A, C, D and E in pregnancy-
dc.typeArticle-
dc.identifier.emailSeto, MTY: mimiseto@hku.hk-
dc.identifier.emailCheung, KW: kawang@hku.hk-
dc.identifier.emailHung, IFN: ivanhung@hkucc.hku.hk-
dc.identifier.authorityHung, IFN=rp00508-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.bpobgyn.2020.03.009-
dc.identifier.pmid32305262-
dc.identifier.scopuseid_2-s2.0-85083324131-
dc.identifier.hkuros317178-
dc.identifier.volume68-
dc.identifier.spage44-
dc.identifier.epage53-
dc.identifier.isiWOS:000579855200006-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1521-6934-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats